10.3390/antibiotics12020234
10.3389/fmicb.2021.750662
10.1016/S2666-5247(22)00338-X
10.3390/antibiotics12050860
10.1038/s41579-019-0196-3
10.1016/j.drup.2016.10.002
10.1038/s41467-020-15966-7
10.1128/spectrum.02701-22
10.1016/j.chom.2021.10.002
10.1016/j.tim.2004.11.010
10.1101/cshperspect.a000398
10.2174/092986711795656216
Guerra MES, 2022, Front Cell Infect Microbiol, 12, 877995, 10.3389/fcimb.2022.877995
17. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. USA; n.d.
10.1111/j.1469-0691.2011.03570.x
10.3389/fmicb.2020.587364
10.3389/fmicb.2021.785573
Hassan A, 2011, Braz J Infect Dis, 15, 305, 10.1016/S1413-8670(11)70197-0
10.1186/s12919-019-0176-7
10.1136/bmjopen-2022-065786
10.1038/s41598-023-38871-7
10.1186/s12941-021-00476-1
10.1371/journal.pone.0084361
10.1007/978-3-642-28951-4_8
10.1016/j.chom.2013.05.009
10.1016/j.jiac.2021.09.001
10.1007/978-3-319-09782-4_1